| Prescription Medicines As a result of its long R&D tradition and the specialist skills the Company has developed over time, Angelini now provides a wide range of prescription medicines for the use of medical professionals and the general public. One of Angelini’s distinguishing features is the great attention it devotes to health professionals by offering vocational training in order to keep up with developments in the sector. The Company’s pharmaceutical sales forces/medical visitors maintain close contact with practitioners and provide them with accurate, timely information on pharmacological and scientific advances. For patients, Angelini’s pharmaceuticals and parapharmaceuticals play a key role in maintaining good health and improving and increasing the quality and expectancy of life for people of all ages. The Company’s main therapeutic areas are pain relief, neuropsychiatry, gynaecology, antibiotics, colds and flu, paediatricsand ophthalmology. |
| Generics Angelini’s long experience in manufacturing pharmaceuticals has facilitated the Company’s entry to the generics market, where the Angelini brand is a guarantee of safety and quality. Both in Italy and in Portugal, the Company’s aim is to foster a wider use of generics. This will provide an added impetus to a market with notable growth rates, with positive effects on public health spending. In 2000, the Angelini Group began marketing generic pharmaceuticals through its alliance with Hexal, one of the ten leading German pharmaceutical companies. Since 2003 Angelini has been operating through its own generics companies with their in-depth knowledge of local pharmaceutical markets and experience in the manufacture and marketing of quality pharmaceuticals. In Italy and Portugal, Angelini is present with a select portfolio of active substances: guaranteed pharmaceuticals that comply with the Company’s strictest quality and safety standards. Angelini’s generics provide practitioners and patients with a wide range of pharmaceuticals that include cardiovascular, anti-inflammatory, anti-depressant, antibacterial and gastrointestinal drugs as well as pain relievers. |
| Over-The-Counter Pharmaceuticals Angelini is a significant presence in the Over-The-Counter (OTC) market, with a wide and diversified variety of pharmaceuticals: pain relievers, anti-inflammatory and gastro-intestinal drugs; oral health and hygiene products; eye-care products; psycho-physical well-being remedies; as well as cold and flu medicines. In Italy, Angelini sits alongside the pharmaceutical corporations at the top of the OTC market, and in Spain and Portugal the Angelini Group is successfully replicating the business model that has enabled the Company to achieve this leading position. Brands such as Moment, Tantum Verde and Amuchina have transferred easily across national borders as confirmation of the efficacy, safety and high tolerability that are a hallmark of Angelini’s pharmaceuticals. Self-treatment of minor ailments does not mean, however, doing without the professional expertise of practitioners or pharmacists. These professional profiles continue to play a vital role in assisting patients by selecting the most suitable treatments and administering drugs correctly. Angelini promotes responsible self-medication and is actively engaged in Patient Education projects implemented along with practitioners, pharmacists and health institutions to safeguard the health and safety of the general public. |
| Mass-Market products and Parapharmaceuticals With a view to strengthening its commitment to day-to-day personal wellbeing, Angelini is active in innovative sectors currently undergoing strong expansion: disinfectant and first-aid products, plant remedies, personal hygiene and cosmetics. A wide variety of wellness products that, while not strictly pharmaceutical, meet the needs of all those with an interest in active prevention and in safeguarding their own wellbeing. Angelini’s recent acquisitions and its entry into the newest, most promising niche markets further reinforce the leading position that the Angelini Group has carved out for itself - in its joint venture with Procter&Gamble - in the Italian market for babies’ nappies and women’s sanitary towels. |